Categories: Business

Donald Trump’s 200% tariffs on pharma: Why India’s generic medicines could still remain competitive

US President Donald Trump on Tuesday announced the final stage of his pharmaceutical tariff plan, under which imported generic medicines will continue to enter the US without duties until August 1, 2028.

The News Vista

Share
Published by
The News Vista

Recent Posts